UNIMED was established in 1989 by its CEO, Ridha Charfeddine, as one of the first pharmaceutical laboratories in Tunisia.
With its human potential and expertise—essential components of its growth—our laboratories have played a significant role in the development of the Tunisian pharmaceutical industry and continue to attract various leading pharmaceutical groups, both in partnership for galenic development and in subcontracting and pharmaceutical shaping.
Thus, we remain committed to our long-term strategy!
UNIMED has expanded its range to now include "ophthalmic, auricular, nasal, and inhalation preparations, liquid injectable forms, pressurized preparations, sterile dry injectable forms of cephalosporins, penicillins, and carbapenems, dietary supplements, medical devices, and biocides." We are committed to our values and will always listen to our partners and clients while remaining open to all technological and scientific innovations.